{
    "clinical_study": {
        "@rank": "109124", 
        "arm_group": {
            "arm_group_label": "COV155", 
            "arm_group_type": "Experimental", 
            "description": "COV155, loading dose of 3 tablets followed by 2 tablets every 12 hours for 10 to 35 days."
        }, 
        "brief_summary": {
            "textblock": "A study to show the safety of COV155 in patients with osteoarthritis of the knee or hip or\n      moderate to severe chronic low back pain."
        }, 
        "brief_title": "Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Osteoarthritis, Knee", 
            "Osteoarthritis, Hip", 
            "Chronic Low Back Pain"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain", 
                "Osteoarthritis", 
                "Osteoarthritis, Hip", 
                "Osteoarthritis, Knee"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  General good health, other than osteoarthritis (OA) or chronic low back pain (CLBP),\n             based upon results of medical and surgical history and medical exam\n\n          -  \u226518 years of age\n\n          -  Voluntarily provide written informed consent\n\n          -  Female subjects eligible if\n\n               1. Not pregnant or lactating; not planning to become pregnant within next 60 days\n\n               2. Surgically sterile, or 2 years postmenopausal, or practicing acceptable birth\n                  control for more than 60 days prior to Screening and use of acceptable birth\n                  control during the study and 7 days following the last dose of COV155\n\n          -  Male subjects biologically capable of having children must use reliable birth control\n             during study and 7 days after the last dose of COV155. Surgical sterilization of the\n             subject's monogamous partner qualifies as adequate birth control\n\n          -  Clinical diagnosis of one of the following\n\n               1. OA of knee or hip for at least 1 year with moderate to severe daily pain despite\n                  chronic use of stable doses of non-steroidal anti-inflammatory drugs (NSAIDs) or\n                  other non-steroidal, non-opioid therapies or with therapy including opioids\n\n               2. Moderate to severe CLBP for at least several hours a day for a minimum of 90\n                  days, not due to a known malignancy, and classified as non-neuropathic,\n                  neuropathic, or symptomatic for more than 6 months after LBP surgery\n\n               3. OA of knee and scheduled to undergo unilateral primary tricompartmental\n                  arthroplasty.\n\n          -  For CLBP/OA: Average in-clinic pain score of \u22653 on 11-point (0 to 10) numerical\n             rating scale (NRS) as an average for the last 24 hours at Screening; - Pain intensity\n             score of \u22654 on NRS as an average for the last 24 hours at Baseline\n\n          -  For TKR: 11. Post-operative pain intensity scores \u2265 4 on a 0 to 10 NRS after\n             discontinuation of post-surgical patient controlled analgesia or intravenous pain\n             medications; body mass index \u2264 38.0; classified as either Physical Status (PS)-1 or\n             PS-2.\n\n        Exclusion Criteria\n\n          -  Any clinically significant condition or unstable illness that precludes study\n             participation or interferes with assessment of pain and other symptoms of CLBP or OA\n             or would increase the risk of opioid or NSAID related adverse events\n\n          -  Schizophrenia or an uncontrolled or poorly controlled major psychiatric condition or\n             clinically significant anxiety or depression\n\n          -  Active malignancy or history of malignancy within 2 years prior to Screening other\n             than dermal or cervical squamous cell carcinoma in situ\n\n          -  History of seizures (exception-pediatric febrile seizures)\n\n          -  Clinically significant ECG abnormalities or uncontrolled hypo- or hypertension\n\n          -  For CLBP/OA: Arthroscopic or open surgery on either the knee or hip selected as\n             primary OA study joint within 6 months prior to Screening; - For CLBP subjects, a\n             surgical procedure for back pain within 6 months prior to Screening, nerve or plexus\n             block within 30 days prior to Screening or botulinum toxin injection in lower back\n             region within 90 days prior to Screening. For OA subjects, joint injection within 30\n             days prior to Screening; - Surgical implants of either the knee or hip selected as\n             the primary OA joint; history of spinal stenosis (only CLBP subjects)\n\n          -  For TKR: Major prior open knee surgery on same side as arthroplasty; any other\n             surgery/elective procedures within 4 weeks of Screening, or during study; going to\n             rehabilitation after surgery\n\n          -  Gastric reduction or gastric band surgery\n\n          -  Taking opioids in equivalents to more than 20 mg hydrocodone or more than 40 mg\n             morphine orally per day, or taking opioid medications 4 days a week or more\n\n          -  Known allergy or hypersensitivity to opioids, acetaminophen or ibuprofen\n\n          -  Certain lab abnormalities\n\n          -  Unable to discontinue use of prohibited medications or history of substance or\n             alcohol abuse within 2 years prior to Screening or positive urine drug test at\n             Screening for alcohol, illicit drugs (including medical cannabis) or controlled\n             substances other than prescribed medications\n\n          -  Positive for human immunodeficiency virus, hepatitis B (surface antigen), and/or\n             hepatitis C\n\n          -  Any other chronic pain condition other than CLBP or OA that would interfere with the\n             assessment of CLBP or OA\n\n          -  Used a monoamine oxidase inhibitor, antipsychotic, or benzodiazepine within 14 days\n             prior to Screening or started or changed doses of anticonvulsants, selective\n             serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, or\n             tricyclic antidepressants within 30 days prior to Screening\n\n          -  Previously received COV155 in a study\n\n          -  Received any investigational drugs or devices within 30 days prior to Screening\n\n          -  Other criteria as specified in the protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "153", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01722864", 
            "org_study_id": "COV15010233"
        }, 
        "intervention": {
            "arm_group_label": "COV155", 
            "description": "COV155 tablets", 
            "intervention_name": "COV155", 
            "intervention_type": "Drug", 
            "other_name": "MNK155"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 13, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92804"
                    }, 
                    "name": "United Clinical Research Center, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Orange County Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Anaheim Clinical Trials"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lomita", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90717"
                    }, 
                    "name": "Torrance Clinical Research Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Ana", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92701"
                    }, 
                    "name": "Probe Clinical Research Corporation - Santa Ana"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eustis", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32726"
                    }, 
                    "name": "Lake Internal Medicine Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hialeah", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33013"
                    }, 
                    "name": "Eastern Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hialeah", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33012"
                    }, 
                    "name": "Palm Springs Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jupiter", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33458"
                    }, 
                    "name": "Health Awareness, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Clinical Neuroscience Solutions Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Compass Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plantation", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33317"
                    }, 
                    "name": "Martin E. Hale, MD PA (Gold Coast Research LLC)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Orange", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32129"
                    }, 
                    "name": "Accord Clinical Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sanford", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32771"
                    }, 
                    "name": "International Clinical Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evansville", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47714"
                    }, 
                    "name": "MediSphere Medical Research Center, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46260"
                    }, 
                    "name": "Goldpoint Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brockton", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02301"
                    }, 
                    "name": "Beacon Clinical Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89103"
                    }, 
                    "name": "Independent Clinical Researchers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asheville", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28803"
                    }, 
                    "name": "Clinical Study Center of Asheville, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }, 
                    "name": "Wake Research Associates LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }, 
                    "name": "The Center for Clinical Research LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45224"
                    }, 
                    "name": "Hightop Physicians Inc./Medical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45227"
                    }, 
                    "name": "Community Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45255"
                    }, 
                    "name": "Community Research - Anderson"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "42542"
                    }, 
                    "name": "New Horizons Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73109"
                    }, 
                    "name": "Health Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greer", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29651"
                    }, 
                    "name": "DeGarmo Institute for Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29406"
                    }, 
                    "name": "Pain Specialists of Charleston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rapid City", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57702"
                    }, 
                    "name": "Health Concepts"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78731"
                    }, 
                    "name": "FutureSearch Trials of Neurology, LP"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77074"
                    }, 
                    "name": "Clinical Trial Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plano", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75023"
                    }, 
                    "name": "ClinRx Research LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78215"
                    }, 
                    "name": "Sun Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22911"
                    }, 
                    "name": "Charlottesville Medical Research Center, LLC"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Safety evaluations using physical exam, vital signs, clinical laboratory tests, pulse oximetry, and adverse events.", 
            "measure": "Safety and tolerability of COV155", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 35 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01722864"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The mean changes from pre-treatment in the worst, least, average, and current pain using the worst, least, average, and current pain intensity items of the mBPI-sf (questions 1 to 4).", 
                "measure": "Modified Brief Pain Inventory short form (mBPI-sf) - intensity", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 1, 2, 3, 4, and 5"
            }, 
            {
                "description": "Evaluate pain relief using the pain relief item of the mBPI-sf (question 5).", 
                "measure": "Modified Brief Pain Inventory short form (mBPI-sf) - pain relief", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 1, 2, 3, 4, and 5"
            }, 
            {
                "description": "Evaluate the pain-related quality of life using the Pain Interference subscale of the mBPI-sf.", 
                "measure": "Modified Brief Pain Inventory short form (mBPI-sf) - pain interference", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 1, 2, 3, 4, and 5"
            }, 
            {
                "description": "The mean changes from pre-treatment in disease-specific quality of life using the WOMAC (48-hour version) for subjects with OA of the hip or knee.", 
                "measure": "Western Ontario and McMaster Universities Arthritis Index (WOMAC)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 1, 2, 3, 4, and 5"
            }, 
            {
                "description": "The mean changes from pre-treatment in disease-specific quality of life using the Roland Morris LBP and Disability Questionnaire for subjects with CLBP.", 
                "measure": "Roland Morris/Disability Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Weeks 1, 2, 3, 4, and 5"
            }
        ], 
        "source": "Mallinckrodt", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mallinckrodt", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}